Evidence map›Paper›PMID 40623689›Full record

ReviewSeminars in respiratory and critical care medicine2025

Survivorship Challenges and Supportive Care in Lung Cancer.

Duc M Ha, Regina A Jacob, Brett C Bade

Abstract readReview
In one paragraph

Review in Seminars in respiratory and critical care medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Duc M HaSection of Pulmonary and Critical Care, Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado.ORCID 0000-0002-3003-9438
Regina A JacobDepartment of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York.ORCID 0000-0002-3192-536X
Brett C BadeDepartment of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York.ORCID 0000-0002-3377-7444

Funding

Rehabilitation Research and Development Service 1IK2RX003661RRD VA IK2 RX003661
6 · The paper itself

Abstract

The number of lung cancer survivors-anyone living with and beyond a lung cancer diagnosis-is increasing along with advances in screening, early detection, and treatment. Following diagnosis and treatment, however, many lung cancer survivors experience high symptom burden and functional challenges that culminate in poor health-related quality of life (HRQL). We incorporated the cancer life course endorsed by the United States National Academy of Medicine (formerly Institute of Medicine) and reviewed interventions to improve HRQL, starting from the time of diagnosis, during or following curative intent treatment, noncurative intent treatment, and continued until changes in disease status and/or goals of care. We reviewed clinical guidelines from the American College of Chest Physicians on HRQL following curative intent therapy, symptom management, and supportive care in lung cancer, as well as the role of exercise-based rehabilitation, complementary therapies, and integrative medicine. Moreover, we identified interventions evaluated in 19 randomized controlled trials (RCTs) or pilot RCTs in the past 10 years, involving 2,506 participants, to address HRQL challenges reported by ≥80% of lung cancer survivors as "important" or "very important": dyspnea, fatigue, sleep difficulties, fear/distress, anxiety, depressive symptoms, physical or role function/independence. This narrative review, which incorporates findings from physical exercise and rehabilitation, cognitive-behavioral and psychological therapies, mind-body therapies, mindfulness-based interventions, and other complementary therapies, has significant implications for enhancing the HRQL of the growing population of lung cancer survivors.

Indexed as

Cancer SurvivorsLung NeoplasmsQuality of LifeSurvivorshipComplementary TherapiesFatigueHumans

Identifiers

PMID40623689
PMCPMC12369273

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.